DE602004030801D1 - Isedronat - Google Patents

Isedronat

Info

Publication number
DE602004030801D1
DE602004030801D1 DE602004030801T DE602004030801T DE602004030801D1 DE 602004030801 D1 DE602004030801 D1 DE 602004030801D1 DE 602004030801 T DE602004030801 T DE 602004030801T DE 602004030801 T DE602004030801 T DE 602004030801T DE 602004030801 D1 DE602004030801 D1 DE 602004030801D1
Authority
DE
Germany
Prior art keywords
hydrate
isedronat
risedronate
ethylidene
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004030801T
Other languages
English (en)
Inventor
Jane Ellen Godlewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Co LLC
Original Assignee
Warner Chilcott Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Chilcott Co LLC filed Critical Warner Chilcott Co LLC
Publication of DE602004030801D1 publication Critical patent/DE602004030801D1/de
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Yarns And Mechanical Finishing Of Yarns Or Ropes (AREA)
  • Pens And Brushes (AREA)
  • Seasonings (AREA)
DE602004030801T 2003-07-30 2004-07-15 Isedronat Active DE602004030801D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49122203P 2003-07-30 2003-07-30
PCT/US2004/022703 WO2005012314A1 (en) 2003-07-30 2004-07-15 Process for controlling crystal structure of risedronate

Publications (1)

Publication Number Publication Date
DE602004030801D1 true DE602004030801D1 (de) 2011-02-10

Family

ID=34115482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004030801T Active DE602004030801D1 (de) 2003-07-30 2004-07-15 Isedronat

Country Status (20)

Country Link
US (1) US7002014B2 (de)
EP (1) EP1651656B1 (de)
JP (1) JP4423614B2 (de)
KR (1) KR100786044B1 (de)
CN (1) CN100439377C (de)
AT (1) ATE493423T1 (de)
AU (1) AU2004261561B9 (de)
BR (1) BRPI0413067A (de)
CA (1) CA2529470C (de)
CO (1) CO5660304A2 (de)
DE (1) DE602004030801D1 (de)
IL (1) IL172676A (de)
IS (1) IS2915B (de)
MA (1) MA27914A1 (de)
MX (1) MXPA06001129A (de)
NO (1) NO335393B1 (de)
NZ (1) NZ544030A (de)
RU (1) RU2319706C2 (de)
SG (1) SG144151A1 (de)
WO (1) WO2005012314A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1775302A1 (de) 2005-10-11 2007-04-18 Sandoz A/S Methode zur Herstellung von kristallinem Natriumrisedronat
JP5052816B2 (ja) * 2006-04-26 2012-10-17 株式会社パーマケム・アジア 3−ピリジル−1−ヒドロキシエチリデン−1、1−ビスホスホン酸ナトリウム塩2.5水和物a型結晶の製造方法
JP5354858B2 (ja) * 2006-05-09 2013-11-27 株式会社Adeka スルホンアミド化合物の金属塩を含有するポリエステル樹脂組成物
US8076483B2 (en) 2006-05-11 2011-12-13 M/S. Ind Swift Laboratories Limited Process for the preparation of pure risedronic acid or salts
WO2008044245A2 (en) * 2006-10-10 2008-04-17 Matrix Laboratories Ltd A process for the preparation of risedronate sodium hemipentahydrate
KR100828705B1 (ko) * 2006-12-04 2008-05-09 씨제이제일제당 (주) 리세드론산 나트륨 수화물의 제조방법
KR100775440B1 (ko) * 2006-12-20 2007-11-12 동우신테크 주식회사 리세드로네이트 나트륨 헤미펜타히드레이트의 제조방법
KR100798855B1 (ko) * 2007-02-14 2008-01-28 주식회사 엔지켐 리세드론산 나트륨 헤미펜타하이드레이트의 제조방법
KR100812528B1 (ko) * 2007-04-12 2008-03-12 보령제약 주식회사 리세드로네이트 나트륨염의 헤미펜타히드레이트의 선택적결정화방법
WO2009050731A2 (en) * 2007-06-20 2009-04-23 Alkem Laboratories Ltd Novel process for preparing risedronic acid
WO2009034580A1 (en) * 2007-09-11 2009-03-19 Fleming Laboratories Limited Improved process for the preparation of risedronate sodium hemipentahydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77243A (en) 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
SK279589B6 (sk) 1991-11-22 1999-01-11 Procter And Gamble Pharmaceuticals Farmaceutický prípravok s retardovaným uvoľňovaním
PE20011061A1 (es) * 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato

Also Published As

Publication number Publication date
AU2004261561A1 (en) 2005-02-10
IS8262A (is) 2006-01-25
AU2004261561B2 (en) 2008-06-26
WO2005012314A1 (en) 2005-02-10
KR20060054297A (ko) 2006-05-22
JP4423614B2 (ja) 2010-03-03
US7002014B2 (en) 2006-02-21
AU2004261561B9 (en) 2008-10-30
CA2529470C (en) 2010-11-23
IS2915B (is) 2014-12-15
RU2006102357A (ru) 2006-07-27
MA27914A1 (fr) 2006-05-02
US20050026869A1 (en) 2005-02-03
NZ544030A (en) 2008-05-30
NO335393B1 (no) 2014-12-08
CA2529470A1 (en) 2005-02-10
IL172676A0 (en) 2006-04-10
EP1651656A1 (de) 2006-05-03
MXPA06001129A (es) 2006-04-11
CN1823078A (zh) 2006-08-23
CN100439377C (zh) 2008-12-03
IL172676A (en) 2010-12-30
JP2007500189A (ja) 2007-01-11
CO5660304A2 (es) 2006-07-31
BRPI0413067A (pt) 2006-10-17
SG144151A1 (en) 2008-07-29
ATE493423T1 (de) 2011-01-15
RU2319706C2 (ru) 2008-03-20
EP1651656B1 (de) 2010-12-29
KR100786044B1 (ko) 2007-12-17
NO20060950L (no) 2006-02-27

Similar Documents

Publication Publication Date Title
NO20060950L (no) Fremgangsmate for a kontrollere krystallstrukturen i risedronat
EA200701358A1 (ru) Кристаллические формы гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1h-3-бензазепина
ATE478082T1 (de) Phosphonate, monophosphonamidate, bisphosphonamidate zur behandlung von virenerkrankungen
HUP0204203A2 (en) Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1,1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate
IL172513A0 (en) Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
WO2003106416A3 (en) CHEMICAL PROCESS
ATE491712T1 (de) Verfahren zur stabilisierung von thiophenderivaten
RS53599B1 (en) PIRIDON DERIVATIVES FOR STRESS MODULATION OF ACTIVATED PROTEIN KINASE SYSTEMS
DE602005015174D1 (de) Verfahren zur herstellung von montelukast-natrium
DK1539711T3 (da) Fremgangsmåde til fremstilling af calciumsaltet af rosuvastatin
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
DE602005026310D1 (de) Verfahren zur herstellung von ibandronat
SV2005002209A (es) Proceso
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
NO20060535L (no) Aztreonam-L-lysin og fremgangsmater for fremstilling av dette
EA200701852A1 (ru) Производные аминокислот
DE602004005881D1 (de) Substituierte pyrazinonverbindungen zur behandlung von entzündungen
ATE372114T1 (de) Verfahren zur erhöhung des testosteronspiegels
DE60238056D1 (de) Verfahren zum kristallisieren von reduziertem coenzym q10 aus wässriger lösung
ZA200800138B (en) Process for the preparation of crystalline perindopril
MXNL04000051A (es) Proceso para la produccion de un inmunosupresor.
DE602005025140D1 (de) Verfahren zur herstellung von alkylphosphinaten
NO20064410L (no) Fremgangsmate for fremstilling av tryptaseinhibitorer
ATE414694T1 (de) Neue heterocyclylethylbenzamid-derivate
ATE344666T1 (de) Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht